Vaxart Inc (VXRT) concluded trading on Thursday at a closing price of $0.72, with 3.3 million shares of worth about $2.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.37% during that period and on Thursday the price saw a gain of about 8.55%. Currently the company’s common shares owned by public are about 227.48M shares, out of which, 225.47M shares are available for trading.
Stock saw a price change of 18.05% in past 5 days and over the past one month there was a price change of 21.34%. Year-to-date (YTD), VXRT shares are showing a performance of 8.55% which increased to 18.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.52 but also hit the highest price of $1.54 during that period. The average intraday trading volume for Vaxart Inc shares is 1.46 million. The stock is currently trading 15.64% above its 20-day simple moving average (SMA20), while that difference is up 8.55% for SMA50 and it goes to -8.05% lower than SMA200.
Vaxart Inc (NASDAQ: VXRT) currently have 227.48M outstanding shares and institutions hold larger chunk of about 23.26% of that.
The stock has a current market capitalization of $163.48M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$0.41 in the same period. It has Quick Ratio of 0.83 while making debt-to-equity ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VXRT, volatility over the week remained 15.93% while standing at 10.33% over the month.
Stock’s fiscal year EPS is expected to rise by 32.16% while it is estimated to increase by 1.72% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on August 15, 2024 offering an Outperform rating for the stock and assigned a target price of $4 to it. Coverage by Jefferies stated Vaxart Inc (VXRT) stock as a Buy in their note to investors on December 29, 2021, suggesting a price target of $12 for the stock. On November 02, 2021, Cantor Fitzgerald Initiated their recommendations, while on June 29, 2021, B. Riley Securities Downgrade their ratings for the stock with a price target of $9. Stock get a Buy rating from Jefferies on June 24, 2021.
